Search Results 151-160 of 13315 for monoclonal antibody

  1. Hong Qin, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Qin's antibody discovery research is focused on developing monoclonal antibodies against both well‐characterized and unknown antigens. To accomplish the former ...

  2. Inotuzumab Ozogamicin And Post-Induction Chemotherapy In Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, And B-LLy - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  3. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

  4. Translational Neuro-Oncology: Jann N. Sarkaria - Research projects

    ADC biology. One promising novel therapeutic approach uses antibody-drug conjugates (ADC). ADCs combine monoclonal antibodies and cytotoxic payloads to target ...

  5. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

  6. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

  7. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

  8. Study Of ACTR087 In Combination With SEA-BCMA In Subjects With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody) in subjects with relapsed or refractory Multiple Myeloma. Participation eligibility. Participant eligibility includes age, gender, type ...

  9. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

  10. Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may block tumor growth in different ... History of severe hypersensitivity reaction to any monoclonal antibody ...